A novel copper-catalyzedaerobicoxidative C(NOH)–C(alkyl) bond cleavage reaction of aryl/aralkyl/vinyl ketones for the synthesis of aromatic/acrylic acids is described. A series of ketones having aryl/aralkyl/vinyl at the one end and methyl to any higher alkyl at the other end can be selectively cleaved and converted into the corresponding acids via oxime intermediates.
PPh<sub>3</sub>⋅HBr-DMSO Mediated Expedient Synthesis of γ-Substituted β,γ-Unsaturated α-Ketomethylthioesters and α-Bromo Enals: Application to the Synthesis of 2-Methylsulfanyl-3(<i>2 H</i>)-furanones
作者:Kanchan Mal、Abhinandan Sharma、Prakas R. Maulik、Indrajit Das
DOI:10.1002/chem.201303755
日期:2014.1.13
An efficient chemoselective general procedure for the synthesis of γ‐substituted β,γ‐unsaturatedα‐ketomethylthioesters from α,β‐unsaturatedketones has been achieved through an unprecedented PPh3⋅HBr‐DMSO mediated oxidative bromination and Kornblum oxidation sequence. The newly developed reagent system serves admirably for the synthesis of α‐bromoenals from enals. Furthermore, AuCl3‐catalyzed efficient
[EN] INHIBITORS OF CYSTATHIONINE BETA SYNTHASE TO REDUCE THE NEUROTOXIC OVERPRODUCTION OF ENDOGENOUS HYDROGEN SULFIDE<br/>[FR] INHIBITEURS DE LA CYSTATHIONINE BÊTA SYNTHASE UTILISABLES EN VUE DE LA RÉDUCTION DE LA SURPRODUCTION NEUROTOXIQUE DE SULFURE D'HYDROGÈNE ENDOGÈNE
申请人:FOND JEROME LEJEUNE
公开号:WO2013068592A1
公开(公告)日:2013-05-16
The invention is directed to inhibitors of cystathionine beta synthase which, among other biochemical effects, allow reduction of the neurotoxic overproduction of endogenous hydrogen sulphide. These compounds and pharmaceutical compositions containing them are useful for the prevention and treatment of cognitive disorders such as cognitive disorders in Down syndrome. The invention also relates to methods for preventing or treating cognitive disorders including cognitive disorders in Down Syndrome.
Design, green synthesis, antioxidant activity screening, and evaluation of protective effect on cerebral ischemia reperfusion injury of novel monoenone monocarbonyl curcumin analogs
of overcoming the instability and pharmacokinetic defects of curcumin possess notable antioxidant activity but are found to be significantly toxic. In this study, a novel skeleton of the monoenone monocarbonyl curcumin analogue sAc possessing reduced toxicity and improved stability was designed on the basis of the DMCA skeleton. Moreover, 32 sAc analogs were obtained by applying a green, simple, and